This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of Uptravi 1,600 MCG tablets. The $11,548.06 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), an agency of the U.S. Department of Defense. The contract has an ultimate completion date of November 26, 2024 and is not associated with any set-aside designations. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a diverse portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to military healthcare facilities and veterans' medical centers nationwide. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of DoD healthcare sites globally.
Generated 2/3/25, 1:37 PM